Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians
Author(s) -
Elizabeth A. Bayliss,
Susan Shetterly,
Melanie L. Drace,
Jonathan D. Norton,
Mahesh Maiyani,
Kathy Gleason,
Jennifer K. Sawyer,
Linda A. Weffald,
Ariel R. Green,
Emily Reeve,
Matthew L. Maciejewski,
Orla C. Sheehan,
Jennifer L. Wolff,
Courtney R. Kraus,
Cynthia M. Boyd
Publication year - 2022
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2022.0502
Subject(s) - medicine , deprescribing , dementia , psychological intervention , polypharmacy , adverse effect , randomized controlled trial , intensive care medicine , psychiatry , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom